Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Fasenra Pen
(United States) [Available] ,Fasenra
(United States) [Available]Synonyms :
Class :
Monoclonal Antibodies, Interleukin Inhibitors, Anti-asthmatics
Dosage Forms & Strengths
Solution
30mg/mL
Dosage Forms & Strengths
Solution
30mg/mL
may increase the risk or severity of adverse effects when combined
It may enhance the adverse effects when combined with sotrovimab
the risk of adverse effects may be increased
Adverse drug reactions:
Frequency Defined
1-10%
Headache
Hypersensitivity reactions
Pharyngitis
Pyrexia
Pregnancy warnings:
Pregnancy Category: N/A
Lactation: unknown if distributed into breast milk, avoid
Pregnancy Categories:
Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.
Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient Information Leaflet
Generic Name: benralizumab
Why do we use benralizumab (Rx)?
benralizumab (Rx) belongs to the class Monoclonal Antibodies, Interleukin Inhibitors, Anti-asthmatics, and it is used to treat severe Asthma.